DOJ argues Anthem, Cigna merger monopolistic in nature: 3 key notes
The U.S. Department of Justice filed a brief on March 13, 2017, arguing the potential merger between Bloomfield, Conn.-based Cigna and Indianapolis-based Anthem would result in increased prices to consumers and hampered innovation in the market, the CT Mirror reports.
Here's what you should know.
1. Cigna appealed a federal judge's ruling against its potential merger with Anthem.
2. The DOJ's brief reaffirms its position from the antitrust trial that the merger would hamper U.S. markets.
3. Anthem presented a plan showing the merger's impact on medical costs. The DOJ said the projected savings from Anthem's medical cost savings plan are "purely aspirational and cannot justify the proposed merger."
More articles on coding, billing and collections:
Judge rules ASC should have access to malpractice insurer data to discover potential bias: 5 things to know
The 4 secrets to scaling your business
7 points on Americans' awareness on key ACA provisions
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
- AAAHC selected to accredit more than 70 correctional health facilities: 4 insights
- GI leader to know: Dr. Brennan Spiegel of Cedars-Sinai
- First impressions matter — AGA shares 5 CV mistakes gastroenterologists should avoid
- Nate Silver: Republican healthcare bill unpopular: 5 insights
- Capital One closes $30.5M loan for medical office building acquisition: 4 insights